MR spectroscopy of brain tumors;Spectroscopie par résonance magnétique des tumeurs cérébrales

Journal de Radiologie

Volumn 87, Issue 6 C2, 2006, Pages 822-832

  Galanaud, D ^a,b   Nicoli, F ^a   Figarella Branger, D ^a   Roche, P ^a   Confort Gouny, S ^a   Le Fur, Y ^a   Cozzone, P J ^a  

^a University of Aix Marseille   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Brain neoplasms, MR; MR, spectroscopy

Indexed keywords

ARTICLE; BRAIN ABSCESS; BRAIN TUMOR; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; DIFFERENTIAL DIAGNOSIS; FOLLOW UP; GLIOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; RADIATION NECROSIS; TUMOR RECURRENCE;

EID: 33745278063     PISSN: 02210363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0221-0363(06)74090-2     Document Type: Article

References (23)

1. Ross B, Bluml S. Magnetic resonance spectroscopy of the human brain. Anat Rec 2001;265:54-84.
2. De Bazelaire C, Lewin M. Points forts en oncologie au RSNA 2004. J Radiol 2005;86:874-84.
3. Grand S, Passaro G, Ziegler A et al. Necrotic tumor versus brain abscess: importance of amino acids detected at 1H MR spectroscopy-initial results. Radiology 1999;213:785-93.
4. Lai PH, Ho JT, Chen WL et al. Brain abscess and necrotic brain tumor: discrimination with proton MR spectroscopy and diffusion-weighted imaging. Am J Neuroradiol 2002;23:1369-77.
5. Poptani H, Gupta RK, Roy R, Pandey R, Jam VK, Chhabra DK. Characterization of intracranial mass lesions with in vivo proton MR spectroscopy. Am J Neuroradiol 1995;16:1593-603.
6. De Edelenyi FS, Rubin C, Esteve F et al. A new approach for analyzing proton magnetic resonance spectroscopic images of brain tumors: nosologic images. Nat Med 2000;6:1287-9.
7. Galanaud D, Chinot O, Metellus P, Cozzone P. Apports de la spectroscopie par résonance magnétique dans l'exploration des gliomes. Bull Cancer 2005;92:327-31.
8. Galanaud D, Nicoli F, Chinot O et al. Non invasive diagnostic assessment of brain tumors using combined in vivo MR imaging and spectroscopy. Magn Reson Med 2006;in press.
9. Galanaud D, Chinot O, Nicoli F et al. Use of proton magnetic resonance spectroscopy of the brain to differentiate gliomatosis cerebri from low-grade glioma. J Neurosurg 2003;98:269-76.
10. Herminghaus S, Dierks T, Pilatus U et al. Determination of histopathological tumor grade in neuroepithelial brain tumors by using spectral pattern analysis of in vivo spectroscopic data. J Neurosurg 2003;98:74-81.
11. Moller-Hartmann W, Herminghaus S, Krings T et al. Clinical application of proton magnetic resonance spectroscopy in the diagnosis of intracranial mass lesions. Neuroradiology 2002;44:371-81.
12. Barba I, Moreno A, Martinez-Perez I et al. Magnetic resonance spectroscopy of brain hemangiopericytomas: high myoinositol concentrations and discrimination from meningiomas. J Neurosurg 2001;94:55-60.
13. Cho YD, Choi GH, Lee SP, Kim JK. (1)H-MRS metabolic patterns for distinguishing between meningiomas and other brain tumors. Magn Reson Imaging 2003;21:663-72.
14. Moreno-Torres A, Martinez-Perez I, Baquero M et al. Taurine detection by proton magnetic resonance spectroscopy in medulloblastoma: contribution to noninvasive differential diagnosis with cerebellar astrocytoma. Neurosurgery 2004;55:824-9.
15. Sirinelli D, Le Flot L. RSNA 2004 : quoi de neuf en radiopédiatrie ? J Radiol 2005;86:885-9.
16. Pierot L. RSNA 2004 : neuroradiologie. J Radiol 2005;86:868-73.
17. Nelson SJ. Imaging of brain tumors after therapy. Neuroimaging Clin N Am 1999;9:801-19.
18. Nelson SJ, Graves E, Pirzkall A et al. In vivo molecular imaging for planning radiation therapy of gliomas: an application of 1H MRSI. J Magn Reson Imaging 2002;16:464-76.
19. Pirzkall A, McKnight TR, Graves EE et al. MR-spectroscopy guided target delineation for high-grade gliomas. Int J Radiat Oncol Biol Phys 2001;50:915-28.
20. Kimura T, Sako K, Gotoh T, Tanaka K, Tanaka T. In vivo single-voxel proton MR spectroscopy in brain lesions with ring-like enhancement. NMR Biomed 2001;14:339-49.
21. Kimura T, Sako K, Tanaka K et al. Evaluation of the response of metastatic brain tumors to stereotactic radiosurgery by proton magnetic resonance spectroscopy, 201TlCl single-photon emission computerized tomography, and gadolinium-enhanced magnetic resonance imaging. J Neurosurg 2004;100:835-41.
22. Yoshino E, Ohmori Y, Imahori Y et al. Irradiation effects on the metabolism of metastatic brain tumors: analysis by positron emission tomography and 1H-magnetic resonance spectroscopy. Stereo-tact Funct Neurosurg 1996;66 Suppl 1:240-59.
23. Murphy PS, Viviers L, Abson C et al. Monitoring temozolomide treatment of low-grade glioma with proton magnetic resonance spectroscopy. Br J Cancer 2004;90:781-6.